Aleafia Health Patient Outcomes Point to Potential Pivot from Opioids and Benzos towards Medical Cannabis—a potential $25 Billion shift Heading into the last week of January, vertically integrated Canadian medicinal... read more →
The California cannabis industry ecosystem is in a state of complete disarray. An industry that has been projected to generate more than $6.5 billion (Arcview Market Research) in revenue by... read more →
News broke recently of a tie-up that shows the medical cannabis industry in a new light: it is a market where more mature players both gain opportunity and give it... read more →
The month of January has historically been a great month for Cannabis stocks and the stock market as a whole. After a brutal finish to 2018 caused by tax loss... read more →
Do you know how a hermit crab keeps itself safe? It moves to new shells to compensate for its lack of natural protection, and with growth, it has to come... read more →
It’s been a big December so far for cannabis, with the Altria/Cronos news sending a strong signal to the broader market that cannabis is here to stay. As with any... read more →
There's a major migration that's already hitting the United States, and most Americans have no idea about it. Some who know what's up are calling it a wave, an influx,... read more →
In the midst of all the hot action in this year’s Canadian marijuana sector, there is one debate that can be heard from the streets of the suburbs to the... read more →
The marijuana sector experienced a wild ride on Wednesday, but none more so than Tilray Inc. (NASDAQ: TLRY). The Canadian cannabis and pharmaceutical company recently made history when American regulatory... read more →
In the ultra-hot marijuana market, MariMed’s rapidly-rising business takes on one of the industry’s best in CV Sciences. Inarguably, one of the hottest trends in the investing markets is legal... read more →
